LENSAR, Inc. (NASDAQ:LNSR) Short Interest Update

LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 208,700 shares, an increase of 92.9% from the March 31st total of 108,200 shares. Currently, 2.3% of the company's stock are sold short. Based on an average daily trading volume, of 174,500 shares, the days-to-cover ratio is presently 1.2 days.

LENSAR Stock Performance

Shares of NASDAQ:LNSR traded down $0.03 during trading on Friday, hitting $13.96. The company's stock had a trading volume of 136,239 shares, compared to its average volume of 73,167. LENSAR has a fifty-two week low of $3.17 and a fifty-two week high of $17.31. The stock's 50-day moving average price is $13.98 and its two-hundred day moving average price is $10.22. The company has a market capitalization of $164.57 million, a PE ratio of -9.56 and a beta of 0.56.

LENSAR (NASDAQ:LNSR - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported ($1.61) EPS for the quarter, missing the consensus estimate of ($0.21) by ($1.40). The business had revenue of $16.73 million for the quarter, compared to analysts' expectations of $14.95 million. LENSAR had a negative net margin of 34.03% and a negative return on equity of 49.02%.

Analysts Set New Price Targets

LNSR has been the subject of a number of analyst reports. Lake Street Capital restated a "hold" rating and issued a $15.00 price target (down previously from $16.00) on shares of LENSAR in a report on Monday, March 24th. BTIG Research lowered shares of LENSAR from a "strong-buy" rating to a "hold" rating in a report on Monday, March 24th.

Hedge Funds Weigh In On LENSAR

Several large investors have recently modified their holdings of the stock. Geode Capital Management LLC lifted its holdings in LENSAR by 3.5% during the 3rd quarter. Geode Capital Management LLC now owns 100,431 shares of the company's stock worth $460,000 after buying an additional 3,423 shares during the last quarter. Atria Investments Inc lifted its stake in LENSAR by 28.2% during the fourth quarter. Atria Investments Inc now owns 26,055 shares of the company's stock worth $233,000 after purchasing an additional 5,729 shares during the last quarter. Brandes Investment Partners LP boosted its holdings in LENSAR by 10.4% in the fourth quarter. Brandes Investment Partners LP now owns 489,318 shares of the company's stock worth $4,375,000 after purchasing an additional 45,920 shares during the period. Renaissance Technologies LLC increased its stake in LENSAR by 13.3% during the fourth quarter. Renaissance Technologies LLC now owns 348,891 shares of the company's stock valued at $3,119,000 after purchasing an additional 40,946 shares during the last quarter. Finally, Essex Investment Management Co. LLC raised its holdings in shares of LENSAR by 18.3% during the fourth quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company's stock worth $357,000 after purchasing an additional 6,184 shares during the period. Institutional investors own 40.15% of the company's stock.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.